Form 8-K - Current report:
SEC Accession No. 0001104659-25-002893
Filing Date
2025-01-13
Accepted
2025-01-13 09:00:18
Documents
41
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253125d1_8k.htm   iXBRL 8-K 32713
2 EXHIBIT 99.1 tm253125d1_ex99-1.htm EX-99.1 41111
6 GRAPHIC tm253125d1_ex99-1img01.jpg GRAPHIC 94874
7 GRAPHIC tm253125d1_ex99-1img02.jpg GRAPHIC 376267
8 GRAPHIC tm253125d1_ex99-1img03.jpg GRAPHIC 205495
9 GRAPHIC tm253125d1_ex99-1img04.jpg GRAPHIC 220598
10 GRAPHIC tm253125d1_ex99-1img05.jpg GRAPHIC 179216
11 GRAPHIC tm253125d1_ex99-1img06.jpg GRAPHIC 172175
12 GRAPHIC tm253125d1_ex99-1img07.jpg GRAPHIC 225848
13 GRAPHIC tm253125d1_ex99-1img08.jpg GRAPHIC 276290
14 GRAPHIC tm253125d1_ex99-1img09.jpg GRAPHIC 67497
15 GRAPHIC tm253125d1_ex99-1img10.jpg GRAPHIC 253684
16 GRAPHIC tm253125d1_ex99-1img11.jpg GRAPHIC 217507
17 GRAPHIC tm253125d1_ex99-1img12.jpg GRAPHIC 209653
18 GRAPHIC tm253125d1_ex99-1img13.jpg GRAPHIC 243413
19 GRAPHIC tm253125d1_ex99-1img14.jpg GRAPHIC 235617
20 GRAPHIC tm253125d1_ex99-1img15.jpg GRAPHIC 275353
21 GRAPHIC tm253125d1_ex99-1img16.jpg GRAPHIC 186501
22 GRAPHIC tm253125d1_ex99-1img17.jpg GRAPHIC 253368
23 GRAPHIC tm253125d1_ex99-1img18.jpg GRAPHIC 228759
24 GRAPHIC tm253125d1_ex99-1img19.jpg GRAPHIC 218833
25 GRAPHIC tm253125d1_ex99-1img20.jpg GRAPHIC 73857
26 GRAPHIC tm253125d1_ex99-1img21.jpg GRAPHIC 207771
27 GRAPHIC tm253125d1_ex99-1img22.jpg GRAPHIC 265604
28 GRAPHIC tm253125d1_ex99-1img23.jpg GRAPHIC 56903
29 GRAPHIC tm253125d1_ex99-1img24.jpg GRAPHIC 163979
30 GRAPHIC tm253125d1_ex99-1img25.jpg GRAPHIC 182807
31 GRAPHIC tm253125d1_ex99-1img26.jpg GRAPHIC 133327
32 GRAPHIC tm253125d1_ex99-1img27.jpg GRAPHIC 80994
  Complete submission text file 0001104659-25-002893.txt   7575094

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA glyc-20250113.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20250113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20250113_pre.xml EX-101.PRE 22369
43 EXTRACTED XBRL INSTANCE DOCUMENT tm253125d1_8k_htm.xml XML 3555
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 25525040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)